All
Research
Education
Business
Solutions
HE
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
AR - العربية
Sign In
Bahram Sharif-Askari has not added Biography.
If you are Bahram Sharif-Askari and would like to personalize this page please email our Author Liaison for assistance.
PARP3 inhibitors ME0328 and olaparib potentiate vinorelbine sensitization in breast cancer cell lines.
Breast cancer research and treatment Nov, 2018 | Pubmed ID: 30039287
Bruton's tyrosine kinase is at the crossroads of metabolic adaptation in primary malignant human lymphocytes.
Scientific reports Jul, 2019 | Pubmed ID: 31363127
PARP Inhibition Sensitizes Breast Cancer Cells to Eribulin.
Frontiers in bioscience (Landmark edition) Mar, 2023 | Pubmed ID: 37005765
The E3 ubiquitin ligase Herc1 modulates the response to nucleoside analogs in acute myeloid leukemia.
Blood advances Oct, 2024 | Pubmed ID: 39093953
Lady Davis Institute for Medical Research
Victor Gife1,2,
Bahram Sharif-Askari3,
Anavasadat Sadr Hashemi Nejad1,2,
Raquel Aloyz3,4,5,
Laura Hulea1,2,6,
François E. Mercier3,4
1, Maisonneuve-Rosemont Hospital Research Centre,
2Department of Biochemistry and Molecular Medicine, University of Montreal,
3, Lady Davis Institute for Medical Research,
4Department of Medicine, McGill University,
5Gerald Bronfman Department of Oncology, McGill University,
6Department of Medicine, University of Montreal
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Playlist
Authors
Librarians
Access
ABOUT JoVE
JoVE Sitemap
Copyright © 2025 MyJoVE Corporation. All rights reserved